In this podcast episode, Ryan Stidham, MD, discusses the evolution and development of digital imaging and AI in the GI space, how AI can revolutionize stages within the clinical trials and practices and more.

• Intro :24
• The interview/about Stidham :36
• Tell us about your family and where you grew up. 1:14
• How did you embrace changes in technology growing up? 3:07
• What was the seminal moment that got you to move from being a consumer of information to being a producer and innovator? 6:05
• What ignited you to start commercializing and patenting your ideas, and operationalizing them into a company? How did that evolution occur? 8:32
• Can you give a quick overview of what these tools and technologies entail? 12:52
• What got you interested in inflammatory bowel disease, and how did your childhood interest in coding shift to artificial intelligence? 18:12
• Where did your interest in AI come about? 20:26
• You recently published a review on how AI will revolutionize the conduct of clinical trials in inflammatory bowel disease […] Will AI remove the need for central reading in IBD trials in the future? 23:58
• How do we change the way we train GI doctors, and should we start making these changes today? 26:38
• With AI rapidly changing the landscape, are we spending enough time educating our fellows in how to adapt to changes and communicate with patients? 32:33
• What do you think will change in IBD and gastroenterology in the near term as a result of AI? 35:06
• What is it that we really need in terms of health care access, and how can AI technology assist these needs? 38:39
• Thank you, Ryan 44:04
• Thanks for listening 44:20

Ryan Stidham, MD, MS, AGAF, is a translational scientist caring exclusively for patients with inflammatory bowel disease. He is an associate professor in the department of medicine and the department of computational medicine and bioinformatics where he serves as the associate chair of translational research. His research focus is the use of artificial intelligence to improving measurement of IBD and other gastrointestinal diseases, developing new interpretations of cross-sectional imaging, endoscopy, medical text, and other electronic data.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Stidham, follow @CrohnsDoc on X.

Disclosures: Berry and Chey report no relevant financial disclosures. Stidham reports consulting or on advisory boards for AbbVie, Bristol Myers Squibb, CorEvitas, Eli Lilly, Exact Sciences, Gilead, Janssen, Merck, Pfizer, and Takeda. Stidham holds intellectual property and equity on medical imaging and endoscopic analysis technologies licensed by the University of Michigan to PreNovo, LLC, AMI, LLC and PathwaysGI, Inc.

In this special crossover episode with Physicianary, previous Gut Talk guest, Austin Chiang, MD, and Physicianary host, Hansa Bhargava, MD, discuss the influence of social media in medicine and how AI continues to change the health care landscape.

• Intro 0:30
• Austin Chiang, MD, MPH 0:36
• Tell us about your journey. 1:02
• How did you get involved with being a social media officer at your institution? 3:58
• Where do you think doctors should see themselves in the future of social media in medicine? 6:49
• What are the ways in which you see AI tech making a difference? 9:12
• Do you agree that it is helpful for doctors to be involved with product development and integration on an industry level? 12:14
• Can you give us some insight on the process of putting through new CPT codes as a company? 14:41
• Tell me more about your book, Gut: An Owner's Guide (The Body Literacy Library). What motivated you to write this book, and what do you think people will get out of it? 18:35
• If you were the “king of health care”, what would you work on first? What is the most important aspect of health car that you think needs fixing? 21:23
• What’s your favorite food? 25:24
• How to reach Chiang. 26:01
• Thanks 26:20

Austin Chiang, MD, MPH, is the first chief medical officer for the endoscopy business of Medtronic, the global leader in health technology. He is also currently an assistant professor of medicine at an academic teaching hospital in Philadelphia, PA, and serves as the director of the Endoscopic Weight Loss Program.

Listen to Gut Talk’s very first episode with Dr. Chiang from 2019, Social Media in Medicine.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. Follow Dr. Bhargava on X @hansabhargavaMD and on Instagram @doctorhansaMD. Follow Dr. Chiang everywhere on social media @AustinChiangMD.

Disclosures: Bhargava reports no relevant financial disclosures. Chiang reports he is the chief medical officer for Medtronic Endoscopy.

In this podcast episode, Prateek Sharma, MD, about how program directors can help shepherd GI fellows into clinical research spaces, providing quality exams for upper endoscopy and more.

• Intro :24
• The interview/about Sharma :43
• Tell us about your family and where you grew up. 1:00
• Did you encourage your son to go into medicine? 2:17
• What kinds of doctors were your parents? 3:40
• Who were your big, early influences? 4:08
• If you didn’t always want to be a doctor, what convinced you to change your mind? 6:11
• When did you make the decision to go into academic medicine as a career? 7:16
• Are you seeing fewer and fewer fellows interested in pursuing a career in academic medicine? […] Are there ways to counsel fellows to be more interested in this type of work? 9:49
• How long have you been a program director, and are you still enjoying the work? 13:58
• How did you choose to into internal medicine and GI? 17:22
• As leaders of academic research centers, what have you done or plan to do in the face of potential cuts to the NIH overhead rates? 18:40
• How are we doing right now as a country and globally in terms of early detection of Barrett's neoplasia? 22:08
• Why has performing high-quality surveillance and screening of procedures like colonoscopy been so much more successful than performing high-quality exams for upper endoscopy? 25:33
• If the biggest hurdle to performing these exams is time, do you feel that more education around how to perform a high-quality exam will move the needle, or are other incentives needed? 28:32
• Do you think AI-based detection is overhyped or underhyped in GI? 30:33
• What are your thoughts on DNA-based testing for conditions like Barrett’s neoplasia, and how should they be incorporated into standard practice? 34:24
• What are your priorities as president of the American Society of Gastrointestinal Endoscopy this year? 38:42
• What do you see as the biggest threats or concerns to gastroenterologists? 42:25
• Final thoughts? 46:32
• Thank you, Prateek 47:13
• Thanks for listening 47:15

Prateek Sharma, MD, FASGE, FACP, FACG, is professor of medicine and director of the GI fellowship program at the University of Kansas School of Medicine.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Sharma, follow @KUcancercenter and @ASGEendoscopy on X and Instagram.

Disclosures: Berry and Chey report no relevant financial disclosures. Sharma reports consulting for Boston Scientific Corporation, CDx Labs, Cipla, Exact Sciences, Medtronic, Olympus Corporation, Salix Pharmaceuticals, Samsung Bioepis and Takeda and provides grant/research support to ERBE USA Inc., Fujifilm Holdings America Corporation, Ironwood Pharmaceuticals Inc. and NEC.